Company intelligence / Profile preview

Hoth Therapeutics

New York, New York, USAhoththerapeutics.com ↗
Ownership
Public · HOTH
Development stage
Other
01

Overview

Hoth Therapeutics has reported positive initial data in a Phase IIa clinical trial for one of its programs. Its lead Alzheimer's candidate HT‑ALZ demonstrated significant cognitive and behavioral benefits in preclinical models. The company’s cancer/immunology program HT-KIT has advanced through key preclinical safety studies with plans to enter first-in-human trials. Overall pipeline includes both clinical and late-preclinical assets addressing high unmet needs in neurology, oncology/allergy/inflammation, and dermatology.

Therapeutic areas
DermatologyOncologyImmunologyNeurology
Modalities
Antisense oligonucleotides (ASO)Small molecules (e.g., NK‑1 receptor antagonist)Proprietary drug formulations
Industry
Biotech
02

Partnerships

Washington University School of Medicine collaboration on Alzheimer’s research/NIH grant applicationpartnerships with OnTargetx R&D Inc. & ITR Laboratories for preclinical studiescollaborations with academic institutions and contract manufacturing organizations are part of their model.

Beyond the preview

Go deeper on Hoth Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hoth Therapeutics.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call